GE HealthCare Doses First Patient in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent
GE HealthCare has dosed the first patient in its Phase 2/3 LUMINA…
FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
The FDA has accepted Roche’s supplemental application for Gazyva/Gazyvaro as a treatment…
KFSH Successfully Implements Gene Therapy for Sickle Cell Disease
King Faisal Specialist Hospital & Research Centre (KFSH) successfully implements gene therapy…
New Study Shows Abbott’s Healthy Food Rx Helps Diabetes Patients Eat Better and Feel Healthier
Late-breaking research presented at the American Diabetes Association's 85th Scientific Sessions showed…